News

  • SCRS Global Summit

    October 8-22, 2015 New Hope attended the Global Site Solutions Summit to gain knowledge and collaborate with other industry professionals and experts in the field of clinical research.  Where Sites, Sponsors & CROs Partner for Success The Global Site Solutions Summit brings together research site executives and industry leaders for powerful collaboration that positions all for success...

    Read More
  • Repairing the brain: Two genes unlock potential for treatment of schizophrenia

    Research led by scientists from Duke-NUS Graduate Medical School Singapore (Duke-NUS) has linked the abnormal behaviour of two genes (BDNF and DTNBP1) to the underlying cause of schizophrenia. These findings have provided a new target for schizophrenia treatment. Schizophrenia is a devastating mental disorder that affects nearly 1% of the total human population. The dominant […]

    Read More
  • Study of Twins Provides Alzheimer’s Blood Protein Clue

    A protein has been discovered in the blood of people who go on to develop mild cognitive impairment several years later. Dr. Steven Kiddle of King’s College London, UK, and colleagues explain there currently are no treatments that can reliably prevent mild cognitive impairment, which can progress into Alzheimer’s disease. Prevention studies are hampered because, […]

    Read More
  • The Hope for Mental Illness

    It has been 10 years since Dr. Tom Insel, director of the National Institute of Mental Health (NIMH) first started attending events held by NAMI. In that time, research on mental illness has continued to grow and new and more effective treatments for mental illness have been developed. But, as Dr. Insel stated in his […]

    Read More
  • 3 Distinct Subtypes of Alzheimer’s

    A new University of California, Los Angeles study finds that Alzheimer’s disease, long thought to be a single disease, really consists of three distinct subtypes. Experts believe the finding could lead to more highly targeted research and, eventually, new treatments for the debilitating neurological disorder, which robs people of their memories. Researchers found that one […]

    Read More
  • NHCR Passes FDA Audit

    Charlotte, N.C. (September 1, 2014)  New Hope Clinical Research, an independent clinical research site, today announced that the U. S. Food and Drug Administration (FDA) concluded its Routine inspection of the New Hope Clinical Trials facility. The inspection took place August 18-26 and reported that New Hope is in full compliance with regulations. The FDA […]

    Read More